Bookmark and Share

Text Size

NPSN Affiliations

NPSN started as a collaborative effort among three partner institutions: the Prostate Cancer Foundation, the Johns Hopkins Hospital, and the Cedars Sinai Medical Center. The network’s online data collection component is intentionally designed to easily add more institutions over time. By increasing the quantity of participating institutions, physicians, researchers, and patients, NPSN aims to improve the quality of its prostate cancer research.

Prostate Cancer Foundation

Prostate Cancer FoundationFirmly committed to curing prostate cancer, the Prostate Cancer Foundation is the leading philanthropic organization funding and accelerating research globally.

Since 1993, PCF’s unique strategies for identifying and investing in the most promising research programs have generated life-saving results. PCF channels resources to the world’s top scientific minds—cutting red tape and encouraging collaboration to speed breakthroughs.

As a champion for increased government and private support, PCF has helped build a global research enterprise of nearly $10 billion. Through the generous contributions of its donors, PCF has funded more than 1,500 programs at nearly 200 research centers in 12 countries.

For more information visit

The Brady Urological Institute at Johns Hopkins Medicine

Johns Hopkins MedicineDrawing on exceptionally brilliant and dedicated people, and outstanding accomplishments in the research field, the Brady Urological Institute has been the international leader in urology for nearly two decades. The Institute was named the #1 urology department by U.S. News & World Report.

The Institute has also achieved world renown for discoveries that led to improvements in the surgical treatment of prostate cancer. Researchers at the institute developed the Proactive Surveillance protocol that serves as the scientific foundation for NPSN.

For more information, visit

Louis Warschaw Prostate Cancer, Uro-oncology Center at Cedars-Sinai Medical Center in los angeles, ca

Cedars-SinaiThe Louis Warschaw Prostate Cancer, Uro-Oncology Center at Cedars-Sinai offers patients access to emerging therapies through its research programs. These programs include integrated prostate cancer clinical trials and a translational research lab that supports pre-clinical and clinical drug studies.

In an ongoing effort to build one of the nation's leading research facilities, the Center is staffed by high-level research professionals. This team collaborates with other leading specialists throughout the country to advance the fight against prostate cancer. Thanks to video conferencing, physicians communicate in real time with academic, scientific, and clinical colleagues anywhere in the world.

For more information, vist